AorticLab

AorticLab is a private MedTech company based in Turin, Italy, dedicated to innovative cardiovascular solutions. The company specializes in improving the treatment of aortic valve stenosis through advanced transcatheter technologies. Founded by experienced professionals in the medical technology field, AorticLab aims to enhance the safety and effectiveness of cardiovascular procedures, particularly Transcatheter Aortic Valve Implantation (TAVI). The company's flagship product, the FLOWer Embolic Protection Device, features a 60 µm mesh designed to protect critical organs during TAVI procedures. This device secures within the aortic arch, reducing the risk of embolic events and improving patient safety. AorticLab is actively involved in pre-clinical and clinical trials, regulatory affairs, and research and development to support its innovative medical devices. The company serves healthcare providers and institutions specializing in cardiovascular care, focusing on enhancing patient outcomes in aortic valve stenosis treatment. AorticLab is ISO 13485 certified and has successfully raised approximately $3.19 million in investments.

• Employees 15
• Founded 2016
• Total Funding $3007008